Fri, Oct 31, 2014, 3:05 AM EDT - U.S. Markets open in 6 hrs 25 mins


% | $
Quotes you view appear here for quick access.

Synthetic Biologics Inc. Message Board

  • tradingmeansfreedom tradingmeansfreedom Nov 15, 2012 12:57 PM Flag

    The only reference to Prev Abr on the entire internet other than the SYN announcement

    March 2012: A PhD named Kieren Marr referencing Prev Abr in her conflicts of interest in a C diff article.

    Oxford Journals
    Mar 12, 2012
    Kieren A. Marr

    Epidemiology and Outcomes of Clostridium difficile Infections in Hematopoietic Stem Cell Transplant Recipients

    K. A. M. has received research funding from Astellas, Merck, and Pfizer;
    and has served on ** advisory boards for Astellas, Merck, Optimer, Pfizer, Prev AbR **

    You can see Prev AbR in the search results abstract, but it is no longer on the page if you click on the link. Implying that she had Oxford replace the file, but the search engine has not cleared their crawl cache. Always take a screen shot for posterity ;) I wouldn't have thought much of it except the paper is about C diff, so it's unlikely to be just a coincidence.

    and more recently

    October 2012: No longer referencing Prev Abr

    October 19, 2012
    Kieren A. Marr, MD (Faculty/Planner) has relevant financial relationships with commercial interests as follows:

    ** Advisory Board: Astellas, Merck, Optimer, Pfizer **
    Consultant: Astellas, Merck, Optimer, Pfizer
    Grant Recipient/Research Support: Funds to JHMI, Astellas, Merck, Pfizer, Sigma Tau

    It appears as if she was either asked to remove it OR Dr. Marr just decided to stop referencing Prev Abr, which is especially odd since these documents seem to be legal, binding, signed potential conflict of interest disclosures. Perhaps because Prev isn't a public company it isn't required.
    Interesting either way, just more cloak and dagger nonsense. There's enough mystery here to keep Scooby and Shaggy busy for an entire season.

1.570.00(0.00%)Oct 30 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.